AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
COMPLEMENTARITY OF STENTING AND ABCIXIMAB FOR PERCUTANEOUS CORONARY INTERVENTION
Authors: KEREIAKES DJ LINCOFF AM SIMOONS ML DEBOER MJ TCHENG JE VAHANIAN A ANDERSON KM WEISMAN HF CALIFF RA TOPOL EJ
Citation: Dj. Kereiakes et al., COMPLEMENTARITY OF STENTING AND ABCIXIMAB FOR PERCUTANEOUS CORONARY INTERVENTION, Journal of the American College of Cardiology, 31(2), 1998, pp. 54-54
DOES INTRACORONARY THROMBUS INFLUENCE THE OUTCOME OF HIGH-RISK PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - CLINICAL AND ANGIOGRAPHIC OUTCOMES IN A LARGE MULTICENTER TRIAL
Authors: KHAN MM ELLIS SG AGUIRRE FV WEISMAN HF WILDERMANN NM CALIFF RM TOPOL EJ KLEIMAN NS
Citation: Mm. Khan et al., DOES INTRACORONARY THROMBUS INFLUENCE THE OUTCOME OF HIGH-RISK PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - CLINICAL AND ANGIOGRAPHIC OUTCOMES IN A LARGE MULTICENTER TRIAL, Journal of the American College of Cardiology, 31(1), 1998, pp. 31-36
RANDOMIZED PLACEBO-CONTROLLED AND BALLOON-ANGIOPLASTY-CONTROLLED TRIAL TO ASSESS SAFETY OF CORONARY STENTING WITH USE OF PLATELET GLYCOPROTEIN-IIB IIIA BLOCKADE/
Authors: TOPOL EJ LINCOFF AM CALIFF RM TCHENG JE KLEIMAN NS ADELMAN AG BURTON JR TALLEY JD IVANHOE RJ DUCAS C CHEUNG PK SCHICK U BADARD D KRAMER J LEARY J SNYDER H WILSON R DEAREN M CARAMORI P WEBBER S TAYLOR J FERRANDO T COHEN E BALLEZA L ROUSE C HOGG N KELLY T ALSTON S WEBB J BULLER E RICCI DR MOCKMAN S TANGUAY JF POITRAS AM TIMIS G DAVEY D COLEMAN P HERROLDRUNGE P ONEILL BJ FOSHEY K FITZGERALD N ALMOND D KOSTUK W WHITE J OSKALNS R GOTTLIEB R KOREN P PALAZZO D AZRIN M BARRY MB BLANKENSHIP J DEMKO SL KRAFT P DVORAK L BROWN R COLCLOUGH M STEVENS K SAREMBOCK I SNYDER L SAYRE S BROWNE K ROY M REEN B SHORT R THOMPSON M CHIODO V HOFFMAN D BASS TA ZENNI M ROHMAN G MARQUIS JF LABINAZ M JELLEY J FRENCH W GOLDBERG S WANG S GRADMAN A BOLTEY L COLLINS J WORLEY S HOLLYWOOD L FREY L YAKUBOV S GILLILAND C RODRIGUEZ A POTTER K TAYLOR M AJI J CLEARY E TANNENBAUM M HARTZ A RUND M SMIGLEY R LOPEZ J KUNNY P HOCHMAN J SLATER J TERMEY D BATES E FOXBRUENGER P GONZALEZ M JOPPERRI L RUNYON JP HIGBY N KRUCOFT M BOOTH T AGUIRRE F BACH R MECHEM C AZRIN M MURPHY D CUMMINS FE NONWEILER J SANZ M COLE C WESTON MW ANDERSON HV WEIGELT L LARKIN T JACKSON BJ ROSENBERG MJ TULLY S HARTMAN C LUNOW S LUCORE C MISHKEL G MCSHANE K MUHLESTEIN B JERMAN J SANDER G STEVENS A CHISHOLM R DELCORE M STENGEL L CANNATA R CASTLE V DELUCA S BALOG C KNUTH T MCCOLLOUGH T GODFREY N MELTON J MILLER D PULLIAM M SAPP S SIGMON KN TEMPLIN M MONTAGUE E CARLSON J HEIL L ZOVKIC V MALONE K RODKEY S HAAS G HARRINGTON R KAPADIS S CAMPBELL L MUKHERJEE D DEEDY M AUGOSTINI R ALEXANDER J WHELLAN D BAJZER C RABBANI R CLEMONS P BAISHNAB R RANDALL R UNDERWOOD D LAUER MA LAUER MS ROE M FARHY R SCHWEIKERT R GRADY T ELLIS S MOLITERNO D DEBOWEY D IVANC T OLS L POLISZCUK R BALAZS E WITHERSPOON B ANDERSON KM BARNATHAN E CABOT CF STONER GL WEISMAN HF
Citation: Ej. Topol et al., RANDOMIZED PLACEBO-CONTROLLED AND BALLOON-ANGIOPLASTY-CONTROLLED TRIAL TO ASSESS SAFETY OF CORONARY STENTING WITH USE OF PLATELET GLYCOPROTEIN-IIB IIIA BLOCKADE/, Lancet, 352(9122), 1998, pp. 87-92
ABCIXIMAB AFFORDS EARLY AND SUSTAINED REPERFUSION BY REDUCED-DOSE RETEPLASE IN A PRIMATE MODEL OF SEVERE ARTERIAL INJURY
Authors: JORDAN RE NAKADA MT MASCELLI MA MACE KF NEDELMAN MA BARNATHAN ES WEISMAN HF
Citation: Re. Jordan et al., ABCIXIMAB AFFORDS EARLY AND SUSTAINED REPERFUSION BY REDUCED-DOSE RETEPLASE IN A PRIMATE MODEL OF SEVERE ARTERIAL INJURY, Circulation, 98(17), 1998, pp. 2765-2765
ABCIXIMAB THERAPY AND UNPLANNED CORONARY STENT DEPLOYMENT - FAVORABLEEFFECTS ON STENT USE, CLINICAL OUTCOMES, AND BLEEDING COMPLICATIONS
Authors: KEREIAKES DJ LINCOFF AM MILLER DP TCHENG JE CABOT CF ANDERSON KM WEISMAN HF CALIFF RM TOPOL EJ
Citation: Dj. Kereiakes et al., ABCIXIMAB THERAPY AND UNPLANNED CORONARY STENT DEPLOYMENT - FAVORABLEEFFECTS ON STENT USE, CLINICAL OUTCOMES, AND BLEEDING COMPLICATIONS, Circulation, 97(9), 1998, pp. 857-864
DIABETES-MELLITUS, GLYCOPROTEIN IIB IIIA BLOCKADE, AND HEPARIN - EVIDENCE FOR A COMPLEX INTERACTION IN A MULTICENTER TRIAL/
Authors: KLEIMAN NS LINCOFF AM KEREIAKES DJ MILLER DP AGUIRRE FV ANDERSON KM WEISMAN HF CALIFF RM TOPOL EJ
Citation: Ns. Kleiman et al., DIABETES-MELLITUS, GLYCOPROTEIN IIB IIIA BLOCKADE, AND HEPARIN - EVIDENCE FOR A COMPLEX INTERACTION IN A MULTICENTER TRIAL/, Circulation, 97(19), 1998, pp. 1912-1920
PHARMACODYNAMIC PROFILE OF SHORT-TERM ABCIXIMAB TREATMENT DEMONSTRATES PROLONGED PLATELET INHIBITION WITH GRADUAL RECOVERY FROM GP IIB IIIARECEPTOR BLOCKADE/
Authors: MASCELLI MA LANCE ET DAMARAJU L WAGNER CL WEISMAN HF JORDAN RE
Citation: Ma. Mascelli et al., PHARMACODYNAMIC PROFILE OF SHORT-TERM ABCIXIMAB TREATMENT DEMONSTRATES PROLONGED PLATELET INHIBITION WITH GRADUAL RECOVERY FROM GP IIB IIIARECEPTOR BLOCKADE/, Circulation, 97(17), 1998, pp. 1680-1688
CONCEPT AND CLINICAL-APPLICATION OF PLATELET GLYCOPROTEIN IIB IIIA INHIBITION WITH ABCIXIMAB (C7E3 FAB - REOPRO) FOR THE PREVENTION OF ACUTE ISCHEMIC SYNDROMES/
Authors: ANDERSON HV JORDAN RE WEISMAN HF
Citation: Hv. Anderson et al., CONCEPT AND CLINICAL-APPLICATION OF PLATELET GLYCOPROTEIN IIB IIIA INHIBITION WITH ABCIXIMAB (C7E3 FAB - REOPRO) FOR THE PREVENTION OF ACUTE ISCHEMIC SYNDROMES/, Clinical and applied thrombosis/hemostasis, 3(4), 1997, pp. 256-266
EVIDENCE FOR PREVENTION OF DEATH AND MYOCARDIAL-INFARCTION WITH PLATELET MEMBRANE GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE BY ABCIXIMAB (C7E3 FAB) AMONG PATIENTS WITH UNSTABLE ANGINA UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION/
Authors: LINCOFF AM CALIFF RM ANDERSON KM WEISMAN HF AGUIRRE FV KLEIMAN NS HARRINGTON RA TOPOL EJ
Citation: Am. Lincoff et al., EVIDENCE FOR PREVENTION OF DEATH AND MYOCARDIAL-INFARCTION WITH PLATELET MEMBRANE GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE BY ABCIXIMAB (C7E3 FAB) AMONG PATIENTS WITH UNSTABLE ANGINA UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION/, Journal of the American College of Cardiology, 30(1), 1997, pp. 149-156
BENEFITS OF ABCIXIMAB ACCRUE IN THE FULL SPECTRUM OF CORONARY INTERVENTIONAL PATIENTS - INSIGHTS FROM THE EPILOG TRIAL
Authors: TCHENG JE LINCOFF AM MILLER DP BOOTH JE RUND MM CABOT CF WEISMAN HF CALIFF RM TOPOL EJ
Citation: Je. Tcheng et al., BENEFITS OF ABCIXIMAB ACCRUE IN THE FULL SPECTRUM OF CORONARY INTERVENTIONAL PATIENTS - INSIGHTS FROM THE EPILOG TRIAL, Journal of the American College of Cardiology, 29(2), 1997, pp. 9931-9931
IN-VITRO CHARACTERIZATION OF DETHROMBOSIS BY ABCIXIMAB (REOPRO)
Authors: MASCELLI MA MARCINIAK SJ WEISMAN HF JORDAN R
Citation: Ma. Mascelli et al., IN-VITRO CHARACTERIZATION OF DETHROMBOSIS BY ABCIXIMAB (REOPRO), Thrombosis and haemostasis, 1997, pp. 2696-2696
LONG-TERM PROTECTION FROM MYOCARDIAL ISCHEMIC EVENTS IN A RANDOMIZED TRIAL OF BRIEF INTEGRIN BETA(3) BLOCKADE WITH PERCUTANEOUS CORONARY INTERVENTION
Authors: TOPOL EJ FERGUSON JJ WEISMAN HF TCHENG JE ELLIS SG KLEIMAN NS IVANHOE RJ WANG AL MILLER DP ANDERSON KM CALIFF RM
Citation: Ej. Topol et al., LONG-TERM PROTECTION FROM MYOCARDIAL ISCHEMIC EVENTS IN A RANDOMIZED TRIAL OF BRIEF INTEGRIN BETA(3) BLOCKADE WITH PERCUTANEOUS CORONARY INTERVENTION, JAMA, the journal of the American Medical Association, 278(6), 1997, pp. 479-484
PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE AND LOW-DOSE HEPARINDURING PERCUTANEOUS CORONARY REVASCULARIZATION/
Authors: TOPOL EJ CALIFF RM LINCOFF AM TCHENG JE CABOT CF WEISMAN HF KEREIAKES D LAUSTEN D RUNYON JP HOWARD W KELLY T MUNCY D TIMMIS G SAFIAN M DAVEY D KLEIMAN NS ROSE D BASINGER L ROUSE C KRAMER J WILSON R TALLEY JD BOYLES M NAVETTA FI LEBUEUF R KRAFT P DVORAK L SMIGLA RM FERGUSON J HARLAN M BROWNE K TELATNIK M BLANKENSHIP J DEMKO L IVANHOE RJ JACKSON C SHADOFF N GOEBEL S TAYLOR M CLEARY E GACIOCH G CHIODO V BATES E QUAIN L SNYDER H BASS TA ROHMAN C GRADMAN A BOLTEY L TANNENBAUM M STENGL D GORDON P WRIGHT N CUMMINS F NONNWEILER J AVERSANO T PELTZER L BEAR P CRAIG MB HATTEL L TOOKE G ANDERSON HV WEIGELT L HETTLEMAN B KENNEDY S TEIRSTEIN PS CLAIRE D SAREMBOCK I SAYRE S DAVIDSON CJ SCHAECHTER A AGUIRRE F STONNER T AZRIN M BODETT J BARRY MB WORLEY S FREY LA SPRIGGS DJ WAHL SA WESTON MW YEDINAK K GEORGE B SMITH D GILLILAND C SMITH D RICCI DR FOX R HARTMAN C LUNOW S FARAH T PETRUOLO S SANDER G STEVENS A DELISE K REEN B WHISNANT D HENDERSON L HEUSER R SWIDERSKI K KALUZNIAK M LARKIN T JACKSON BJ POPMA J PRUNKA N SANZ M MAYER D MACKEY K BURTON J HOGG N BROWN R STEVENS K FRENCH W WANG S ADELMAN AG FOULGER V WEBER S GOTTLIEB R LAVOIE J KING S FRERICHS F HOLLYWOOD L DUCAS J SCHICK U HOCHMAN JS SLATER J TORMEY D ONEILL BJ FOSHAY K FITZGERALD N CHEUNG PK BEDARD D KNUDTSON ML GALBRAITH D WATT H SAMAHA J HAMILTON B KLEIN LW HEBSON L ALMOND D WHITE J ROSENBERG MJ TEULLY S UNKS M RODGERS K FAXON D GORE J KELSEY S LEE K SANE D WALTERS L BOOTH J CANNATA R CASTLE V COHEN H DELUCA S KUTNER M KNUTH T MCCOLLOUGH T MCPHERSON J MELTON J MILLER D PULLIAM M SAPP S SIGMON KN MONTAGUE E ALEXANDER K AUGOSTINI R BAJZER C BART B BELLI G CARLSON J CHALLAPALLI R CRENSHAW B DAWSON I DICKEY A ECHOLS A ERICKSON B FONTANA MB GHAFFARI S GORDON C GRANGER C GRANO G GRIMM R JOHNSON T JURAN N KINGSLEY A KRUSE K LAUER M MAHAFFEY K MALONE K MARK D MARWICK T MIGRINO R MILLER J NEWBY K PACE C PETERSON E RABBANI R RAGAN J RIMMERMAN C RODKEY S SAVOR V SHAW WF SILA C SILVER M TAN W TOBIASZ D VANDERVOORT P WANG CW WARD C WATERS J WIEHLE D WINCHELL M UNDERWOOD D CLEMONS P HEUPLER S POWERS J RUBIN D SGARBOSSA E STEINHUBL S MOLITERNO D DEBOWEY D BALAZS E CROWE T IVANC T OLS L POLISZCZUK R VILSACK H WITHERSPOON B DAVIDSONRAY L ANDERSON KM GIEL KM MUSCO MH STONER GL
Citation: Ej. Topol et al., PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE AND LOW-DOSE HEPARINDURING PERCUTANEOUS CORONARY REVASCULARIZATION/, The New England journal of medicine, 336(24), 1997, pp. 1689-1696
LONG-TERM MORTALITY BENEFIT WITH ABCIXIMAB IN PATIENTS UNDERGOING PERCUNTANTEOUS CORONARY INTERVENTION (PCI)
Authors: ANDERSON KM FERGUSON JI STONER GL CABOT CF WEISMAN HF
Citation: Km. Anderson et al., LONG-TERM MORTALITY BENEFIT WITH ABCIXIMAB IN PATIENTS UNDERGOING PERCUNTANTEOUS CORONARY INTERVENTION (PCI), Circulation, 96(8), 1997, pp. 903-903
ABCIXIMAB REDUCES RISK OF UNPLANNED CORONARY STENT DEPLOYMENT - EPILOG TRIAL RESULTS
Authors: KEREIAKES DJ LINCOFF AM MILLER DP TCHENG JE WEISMAN HF TOPOL EJ
Citation: Dj. Kereiakes et al., ABCIXIMAB REDUCES RISK OF UNPLANNED CORONARY STENT DEPLOYMENT - EPILOG TRIAL RESULTS, Circulation, 96(8), 1997, pp. 906-906
ABCIXIMAB CAUSES PROFOUND, IMMEDIATE INHIBITION OF PLATELET-FUNCTION THAT RECOVERS GRADUALLY AFTER PTCA
Authors: JORDAN RE MASCELLI MA NAKADA MT WEISMAN HF
Citation: Re. Jordan et al., ABCIXIMAB CAUSES PROFOUND, IMMEDIATE INHIBITION OF PLATELET-FUNCTION THAT RECOVERS GRADUALLY AFTER PTCA, Circulation, 96(8), 1997, pp. 4041-4041
RAPID ASSESSMENT OF PLATELET-FUNCTION WITH A MODIFIED WHOLE-BLOOD AGGREGOMETER IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PATIENTS RECEIVING ANTI-GP IIB IIIA THERAPY/
Authors: MASCELLI MA WORLEY S VERIABO NJ LANCE ET MACK S SCHAIBLE T WEISMAN HF JORDAN RE
Citation: Ma. Mascelli et al., RAPID ASSESSMENT OF PLATELET-FUNCTION WITH A MODIFIED WHOLE-BLOOD AGGREGOMETER IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY PATIENTS RECEIVING ANTI-GP IIB IIIA THERAPY/, Circulation, 96(11), 1997, pp. 3860-3866
RECOVERY OF PLATELET-FUNCTION AFTER REOPRO TREATMENT - GRADUAL TAPERING OF ANTITHROMBOTIC ACTIVITY BUT RAPID RECOVERY OF HEMOSTATIC POTENTIAL
Authors: JORDAN RE NAKADA MT WAGNER CL LANCE ET MASCELLI MA WEISMAN HF
Citation: Re. Jordan et al., RECOVERY OF PLATELET-FUNCTION AFTER REOPRO TREATMENT - GRADUAL TAPERING OF ANTITHROMBOTIC ACTIVITY BUT RAPID RECOVERY OF HEMOSTATIC POTENTIAL, The American journal of cardiology, 80, 1997, pp. 1-1
STANDARD VERSUS LOW-DOSE WEIGHT-ADJUSTED HEPARIN IN PATIENTS TREATED WITH THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTIBODY FRAGMENT ABCIXIMAB (C7E3 FAB) DURING PERCUTANEOUS CORONARY REVASCULARIZATION/
Authors: LINCOFF AM TCHENG JE CALIFF RM BASS T POPMA JJ TEIRSTEIN PS KLEIMAN NS HATTEL LJ ANDERSON HV FERGUSON JJ CABOT CF ANDERSON KM BERDAN LG MUSCO MH WEISMAN HF TOPOL EJ
Citation: Am. Lincoff et al., STANDARD VERSUS LOW-DOSE WEIGHT-ADJUSTED HEPARIN IN PATIENTS TREATED WITH THE PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR ANTIBODY FRAGMENT ABCIXIMAB (C7E3 FAB) DURING PERCUTANEOUS CORONARY REVASCULARIZATION/, The American journal of cardiology, 79(3), 1997, pp. 286-291
REOPRO CLINICAL DEVELOPMENT - FUTURE-DIRECTIONS AND THERAPEUTIC APPROACHES
Authors: WEISMAN HF
Citation: Hf. Weisman, REOPRO CLINICAL DEVELOPMENT - FUTURE-DIRECTIONS AND THERAPEUTIC APPROACHES, The Journal of invasive cardiology, 8, 1996, pp. 51-61
INCREASED RISK OF NON-Q-WAVE MYOCARDIAL-INFARCTION AFTER DIRECTIONAL ATHERECTOMY IS PLATELET DEPENDENT - EVIDENCE FROM THE EPIC TRIAL
Authors: LEFKOVITS J BLANKENSHIP JC ANDERSON KM STONER GL TALLEY JD WORLEY SJ WEISMAN HF CALIFF RM TOPOL EJ
Citation: J. Lefkovits et al., INCREASED RISK OF NON-Q-WAVE MYOCARDIAL-INFARCTION AFTER DIRECTIONAL ATHERECTOMY IS PLATELET DEPENDENT - EVIDENCE FROM THE EPIC TRIAL, Journal of the American College of Cardiology, 28(4), 1996, pp. 849-855
THE ANTI-GPIIB-IIIA AGENTS - FUNDAMENTAL AND CLINICAL ASPECTS
Authors: COLLER BS ANDERSON KM WEISMAN HF
Citation: Bs. Coller et al., THE ANTI-GPIIB-IIIA AGENTS - FUNDAMENTAL AND CLINICAL ASPECTS, Haemostasis, 26, 1996, pp. 285-293
ABCIXIMAB [7E3] PHARMACODYNAMICS DEMONSTRATES AN EXTENDED AND GRADUALRECOVERY FROM GPIIB IIIA BLOCKADE/
Authors: MASCELLI MA LANCE ET WAGNER CL WEISMAN HF JORDAN RE
Citation: Ma. Mascelli et al., ABCIXIMAB [7E3] PHARMACODYNAMICS DEMONSTRATES AN EXTENDED AND GRADUALRECOVERY FROM GPIIB IIIA BLOCKADE/, Circulation, 94(8), 1996, pp. 3008-3008
PREIMMUNE REACTIVITY TO ABCIXIMAB (C7E3 FAB) DOES NOT HAVE ANY CLINICAL EFFECT ON EFFICACY, PLATELET COUNT, OR PHARMACOKINETICS
Authors: SCHANTZ AR WAGNER CL WEISMAN HF JORDAN RE
Citation: Ar. Schantz et al., PREIMMUNE REACTIVITY TO ABCIXIMAB (C7E3 FAB) DOES NOT HAVE ANY CLINICAL EFFECT ON EFFICACY, PLATELET COUNT, OR PHARMACOKINETICS, Circulation, 94(8), 1996, pp. 3009-3009
ANALYSIS OF GPIIB IIIA RECEPTOR NUMBER BY QUANTIFICATION OF 7E3 BINDING TO HUMAN PLATELETS/
Authors: WAGNER CL MASCELLI MA NEBLOCK DS WEISMAN HF COLLER BS JORDAN RE
Citation: Cl. Wagner et al., ANALYSIS OF GPIIB IIIA RECEPTOR NUMBER BY QUANTIFICATION OF 7E3 BINDING TO HUMAN PLATELETS/, Blood, 88(3), 1996, pp. 907-914
Risultati: 1-25 | 26-50 | 51-54